Upgrade to SI Premium - Free Trial

Phio Pharmaceuticals Corp. (PHIO)

1.08 -0.03 (2.70%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Form 4 Phio Pharmaceuticals For: Aug 19 Filed by: Plott Ronald Todd August 20, 2026 8:30 AM - SEC Filing Form 4 Phio Pharmaceuticals For: Aug 18 Filed by: Bitterman Robert J August 19, 2026 4:01 PM - SEC Filing Form ARS Phio Pharmaceuticals For: Dec 31 August 14, 2026 4:19 PM - SEC Filing Form DEFA14A Phio Pharmaceuticals August 14, 2026 4:18 PM - SEC Filing Form DEF 14A Phio Pharmaceuticals For: Sep 28 August 14, 2026 4:08 PM - SEC Filing Phio Pharmaceuticals receives U.S. patent allowance for PH-894 August 11, 2026 7:02 AM - StreetInsider Phio Pharmaceuticals Secures U.S. Notice of Allowance for INTASYL Composition Selectively Targeting BRD4 Protein with Compound PH-894 August 11, 2026 7:02 AM - StreetInsider Phio Pharmaceuticals Corp. (PHIO) Misses Q2 EPS by 6c August 6, 2026 6:04 PM - StreetInsider Form 8-K Phio Pharmaceuticals For: Aug 06 August 6, 2026 4:22 PM - SEC Filing Form 10-Q Phio Pharmaceuticals For: Jun 30 August 6, 2026 4:19 PM - SEC Filing Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update August 6, 2026 4:07 PM - StreetInsider Form 3 Phio Pharmaceuticals For: Jul 20 Filed by: Plott Ronald Todd July 30, 2026 4:01 PM - SEC Filing Correction to Announcement Regarding Phio Pharmaceuticals Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series July 22, 2026 12:31 PM - StreetInsider Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series July 22, 2026 7:02 AM - StreetInsider Form 8-K Phio Pharmaceuticals For: Jul 21 July 21, 2026 7:08 AM - SEC Filing Phio Pharmaceuticals adds dermatologist to its board of directors July 21, 2026 7:01 AM - StreetInsider Phio Pharmaceuticals Announces Appointment of Dr. R. Todd Plott to the Board of Directors July 21, 2026 7:01 AM - StreetInsider Phio Pharmaceuticals receives patent approvals in U.S., Canada, and Japan July 15, 2026 7:02 AM - StreetInsider Phio Pharmaceuticals Announces Patent Milestone with Multiple Notices of Allowance and Grant Decision July 15, 2026 7:02 AM - StreetInsider Form 4 Phio Pharmaceuticals For: Jun 26 Filed by: Bitterman Robert J June 29, 2026 4:02 PM - SEC Filing Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing June 26, 2026 8:35 AM - StreetInsider Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series June 26, 2026 7:02 AM - StreetInsider Phio Pharmaceuticals Announces "How siRNA Therapy can Change the Course of Cancer Treatment" in a Fireside Chat with Force Family Office on Monday, June 29, 2026 June 25, 2026 7:02 AM - StreetInsider Phio Pharmaceuticals begins commercial-scale production of PH-762 June 24, 2026 7:02 AM - StreetInsider Phio Pharmaceuticals Reaches Key Milestone in Advancing Lead Candidate PH-762 June 24, 2026 7:02 AM - StreetInsider Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th June 23, 2026 8:35 AM - Globe NewsWire Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th June 23, 2026 8:35 AM - StreetInsider Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026 June 18, 2026 7:02 AM - StreetInsider Full Article List